Last reviewed · How we verify

NCT06552663

The Diagnostic Power Of Coronary CT Angiography In Patients With Chest Pain And Zero Calcium Score

Not yet recruiting Last updated 14 August 2024
What this trial tests

trial testing CCTA in CT - Coronary Thrombosis in 75 participants. Not yet recruiting.

Timeline
1 September 2024
Primary endpoint
1 September 2025
1 December 2025

Quick facts

Lead sponsorAssiut University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment75
Start date1 September 2024
Primary completion1 September 2025
Estimated completion1 December 2025

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Eligibility, any sex, with CT - Coronary Thrombosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To prove the non-used wide diagnostic range of CCTA in diagnosis of other causes of chest pain in addition to the traditional known role in coronary atherosclerosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of CCTA

Trials testing the same drug.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06552663.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing